Kenvue Inc. $KVUE Shares Purchased by Wealthfront Advisers LLC

Wealthfront Advisers LLC lifted its stake in Kenvue Inc. (NYSE:KVUE) by 117.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 306,713 shares of the company’s stock after purchasing an additional 165,868 shares during the quarter. Wealthfront Advisers LLC’s holdings in Kenvue were worth $5,291,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Salomon & Ludwin LLC acquired a new stake in shares of Kenvue in the third quarter valued at approximately $25,000. NBT Bank N A NY increased its position in Kenvue by 180.3% during the third quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after purchasing an additional 1,006 shares during the last quarter. Cornerstone Planning Group LLC increased its position in Kenvue by 705.2% during the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock worth $25,000 after purchasing an additional 1,361 shares during the last quarter. Physician Wealth Advisors Inc. increased its position in Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after purchasing an additional 618 shares during the last quarter. Finally, Golden State Wealth Management LLC increased its position in Kenvue by 150.1% during the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock worth $32,000 after purchasing an additional 1,190 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on KVUE shares. UBS Group cut their price objective on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research report on Tuesday, April 7th. Argus upgraded shares of Kenvue to a “hold” rating in a research report on Friday, March 6th. Canaccord Genuity Group raised their price objective on shares of Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Wednesday, February 18th. Citigroup cut their target price on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Finally, Barclays cut their target price on Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 14th. Three research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company’s stock. According to MarketBeat, Kenvue currently has a consensus rating of “Hold” and an average target price of $19.33.

Kenvue Trading Up 2.0%

Shares of KVUE stock opened at $17.58 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.96. The stock has a market capitalization of $33.74 billion, a P/E ratio of 22.82, a price-to-earnings-growth ratio of 3.91 and a beta of 0.61. The company has a 50 day moving average price of $17.72 and a 200 day moving average price of $17.17. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $25.17.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. The firm had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $3.68 billion. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The business’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.26 earnings per share. Equities research analysts predict that Kenvue Inc. will post 1.1 EPS for the current fiscal year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th will be paid a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 4.7%. The ex-dividend date of this dividend is Wednesday, May 13th. Kenvue’s payout ratio is presently 107.79%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.